BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17397254)

  • 41. Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120.
    Chandramouli B; Chillemi G; Abbate I; Capobianchi MR; Rozera G; Desideri A
    J Biomol Struct Dyn; 2012; 29(5):879-91. PubMed ID: 22292949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5.
    Zhukovsky MA; Lee PH; Ott A; Helms V
    Proteins; 2013 Apr; 81(4):555-67. PubMed ID: 23161741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantially.
    Thielen A; Lengauer T; Swenson LC; Dong WW; McGovern RA; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    Antivir Ther; 2011; 16(3):319-28. PubMed ID: 21555814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SCOTCH: subtype A coreceptor tropism classification in HIV-1.
    Löchel HF; Riemenschneider M; Frishman D; Heider D
    Bioinformatics; 2018 Aug; 34(15):2575-2580. PubMed ID: 29554213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.
    Tamamis P; Floudas CA
    PLoS One; 2014; 9(4):e95767. PubMed ID: 24763408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV.
    Bozek K; Thielen A; Sierra S; Kaiser R; Lengauer T
    PLoS One; 2009 Oct; 4(10):e7387. PubMed ID: 19816596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection.
    Li Y; Rey-Cuille MA; Hu SL
    AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1473-9. PubMed ID: 11709091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor.
    Suphaphiphat P; Essex M; Lee TH
    Virology; 2007 Mar; 360(1):182-90. PubMed ID: 17101166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage.
    Shah M; Smit TK; Morgello S; Tourtellotte W; Gelman B; Brew BJ; Saksena NK
    AIDS Res Hum Retroviruses; 2006 Feb; 22(2):177-81. PubMed ID: 16478400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of novel molecular determinants of co-receptor usage in HIV-1 subtype F V3 envelope sequences.
    Distefano M; Lanzarotti E; Fernández MF; Mangano A; Martí M; Aulicino P
    Sci Rep; 2020 Jul; 10(1):12583. PubMed ID: 32724045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV-1 gp120 V3 loop for structure-based drug design.
    Sirois S; Sing T; Chou KC
    Curr Protein Pept Sci; 2005 Oct; 6(5):413-22. PubMed ID: 16248793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new perspective on V3 phenotype prediction.
    Pillai S; Good B; Richman D; Corbeil J
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):145-9. PubMed ID: 12643277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop.
    Tamamis P; Floudas CA
    Biophys J; 2013 Sep; 105(6):1502-14. PubMed ID: 24048002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotypic prediction of HIV-1 CRF01-AE tropism.
    Raymond S; Delobel P; Rogez S; Encinas S; Bruel P; Pasquier C; Sandres-Sauné K; Marchou B; Massip P; Izopet J
    J Clin Microbiol; 2013 Feb; 51(2):564-70. PubMed ID: 23224099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility.
    Registre L; Moreau Y; Ataca ST; Pulukuri S; Henrich TJ; Lin N; Sagar M
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31694950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.
    Nedellec R; Coetzer M; Lederman MM; Offord RE; Hartley O; Mosier DE
    PLoS One; 2011; 6(7):e22020. PubMed ID: 21760945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones.
    Bagnarelli P; Fiorelli L; Vecchi M; Monachetti A; Menzo S; Clementi M
    Virology; 2003 Mar; 307(2):328-40. PubMed ID: 12667802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage.
    Masso M; Vaisman II
    BMC Bioinformatics; 2010 Oct; 11():494. PubMed ID: 20923564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host.
    Watabe T; Kishino H; Okuhara Y; Kitazoe Y
    Genetics; 2006 Mar; 172(3):1385-96. PubMed ID: 16361230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism.
    Kalinina OV; Pfeifer N; Lengauer T
    Retrovirology; 2013 Nov; 10():130. PubMed ID: 24215935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.